Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort

Amish N. Raval, Peter V. Johnston, Henricus J. Duckers, Thomas D. Cook, Jay H. Traverse, Peter Altman, Ravi Dhingra, Peiman Hematti, Ivan Borrello, R. David Anderson, Carl J. Pepine